Literature DB >> 21474607

Molecular epidemiology of group B streptococcal meningitis in children beyond the neonatal period from Angola.

Carlos Florindo1,2, João P Gomes2, Márcia G Rato1, Luís Bernardino3, Barbara Spellerberg4, Ilda Santos-Sanches1, Maria J Borrego2.   

Abstract

Streptococcus agalactiae is a major pathogen of neonates and immunocompromised adults. Prior studies have demonstrated that, beyond the neonatal period, S. agalactiae rarely causes invasive infections in children. However, during 2004-2005, S. agalactiae was the causative agent of 60 meningitis episodes in children aged 3 months to 12 years from Angola. To identify and study the specific causative genetic lineages of S. agalactiae childhood meningitis, which lack characterization to date, we conducted an extensive molecular analysis of the recovered isolates (n = 21). This constitutes what we believe to be the first molecular study of the population structure of invasive S. agalactiae isolates from Africa. A low genetic diversity was observed among the isolates, where the majority belonged to clonal complex (CC) 17 presenting the capsular subtype III-2 (86 % of cases) and marked by the intron group II GBSi1, which has previously been observed to be associated with neonatal hosts. The predominance of single-locus variants of sequence type (ST) 17 suggested the local diversification of this hypervirulent clone, which displayed novel alleles of the fbsB and sip virulence genes. The absence of the scpB-lmb region in two S. agalactiae isolates with the Ia/ST23 genotype is more typical of cattle than human isolates. Globally, these data provide novel information about the enhanced invasiveness of the CC17 genetic lineage in older children and suggest the local diversification of this clone, which may be related to the future emergence of a novel epidemic clone in Angola.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21474607     DOI: 10.1099/jmm.0.031674-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  9 in total

1.  Clinical strains of Streptococcus agalactiae carry two different variants of pathogenicity island XII.

Authors:  Eugenia Kuleshevich; Joseph Ferretti; Ilda Santos Sanches; Natesan Balasubramanian; Barbara Spellerberg; Androulla Efstratiou; Paula Kriz; Kornelia Grabovskaya; Olga Arjanova; Alevtina Savitcheva; Valentin Shevchenko; Anton Rysev; Alexander Suvorov
Journal:  Folia Microbiol (Praha)       Date:  2017-03-18       Impact factor: 2.099

2.  Development of a multiplexed opsonophagocytic killing assay (MOPA) for group B Streptococcus.

Authors:  Min Joo Choi; Ji Yun Noh; Hee Jin Cheong; Woo Joo Kim; Shun-Mei Lin; Yong Zhi; Jae Hyang Lim; Sangyong Lim; Ho Seong Seo; Joon Young Song
Journal:  Hum Vaccin Immunother       Date:  2017-10-30       Impact factor: 3.452

3.  High Incidence of Macrolide and Tetracycline Resistance among Streptococcus Agalactiae Strains Isolated from Clinical Samples in Tehran, Iran.

Authors:  Mohammad Emaneini; Akbar Mirsalehian; Reza Beigvierdi; Abbas Ali Imani Fooladi; Fatemeh Asadi; Fereshteh Jabalameli; Morovat Taherikalani
Journal:  Maedica (Buchar)       Date:  2014-06

4.  Group B streptococcal meningitis in children beyond the neonatal period in sub-Himalayan India.

Authors:  Divya Chauhan; Kiran Mokta; Anil Kanga; Neelam Grover; Digvijay Singh; Suruchi Bhagra
Journal:  Ann Indian Acad Neurol       Date:  2015 Jan-Mar       Impact factor: 1.383

Review 5.  Codevelopment of Microbiota and Innate Immunity and the Risk for Group B Streptococcal Disease.

Authors:  Julia Kolter; Philipp Henneke
Journal:  Front Immunol       Date:  2017-11-10       Impact factor: 7.561

6.  Capsular Type, Sequence Type and Microbial Resistance Factors Impact on DNase Activity of Streptococcus agalactiae Strains from Human and Bovine Origin.

Authors:  Carlos Florindo; Cinthia Alves Barroco; Inês Silvestre; Vera Damião; João Paulo Gomes; Barbara Spellerberg; Ilda Santos-Sanches; Maria José Borrego
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2018-12-11

7.  Streptococcus agalactiae Serotype Distribution and Antimicrobial Susceptibility in Pregnant Women in Gabon, Central Africa.

Authors:  Sabine Belard; Nicole Toepfner; Mesküre Capan-Melser; Ghyslain Mombo-Ngoma; Rella Zoleko-Manego; Mirjam Groger; Pierre-Blaise Matsiegui; Selidji T Agnandji; Ayôla A Adegnika; Raquel González; Peter G Kremsner; Clara Menendez; Michael Ramharter; Reinhard Berner
Journal:  Sci Rep       Date:  2015-11-25       Impact factor: 4.379

8.  Associations between nasopharyngeal carriage of Group B Streptococcus and other respiratory pathogens during early infancy.

Authors:  Ebenezer Foster-Nyarko; Brenda Kwambana; Odutola Aderonke; Fatima Ceesay; Sheikh Jarju; Abdoulie Bojang; Jessica McLellan; James Jafali; Beate Kampmann; Martin O Ota; Ifedayo Adetifa; Martin Antonio
Journal:  BMC Microbiol       Date:  2016-05-27       Impact factor: 3.605

9.  Parallel Evolution of Group B Streptococcus Hypervirulent Clonal Complex 17 Unveils New Pathoadaptive Mutations.

Authors:  Alexandre Almeida; Isabelle Rosinski-Chupin; Céline Plainvert; Pierre-Emmanuel Douarre; Maria J Borrego; Claire Poyart; Philippe Glaser
Journal:  mSystems       Date:  2017-09-05       Impact factor: 6.496

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.